In human cancer patients, T cell-infiltrated tumors can show PD-L1 upregulation on either tumor cells or myeloid cells, and each can be associated with anti-PD-1 therapeutic efficacy in defined contexts38. The gene discussed is CD274; the disease is neoplasm.